Stay updated on Pilot Trial Flecainide in ARVC Patients Clinical Trial
Sign up to get notified when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.

Latest updates to the Pilot Trial Flecainide in ARVC Patients Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe study record area displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. This indicates the study details are currently unavailable rather than updated information.SummaryDifference19%

- Check51 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a small template/UI update to the page.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small maintenance/formatting update to the site without changes to study information.SummaryDifference0.0%

Stay in the know with updates to Pilot Trial Flecainide in ARVC Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.